Work

Butyrate, a new microbiota-dependent player in CD8+ T cells immunity and cancer therapy?

Year: 2021
Type: article
Abstract: The intestinal microbiota is a new promising avenue in cancer immunotherapy, but mechanisms remain elusive. He et al. demonstrate that butyrate, a bacterial metabolite, enhances the CD8+ T cell response and improve chemotherapy efficacy through ID2-dependent IL-12 signaling.
Language: English
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W3182490035
FWCI: 1.633
Cites: 10
Cited by: 57
Related to: 10